CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
MedicalSystem Biotechnology Co Ltd Company Snapshot
MedicalSystem Biotechnology Co Ltd operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares MedicalSystem Biotechnology Co Ltd with three other companies in this sector in China: Shanghai Kehua Bio-Engineering Co., Ltd. (2018 sales of 1.99 billion Chinese Renmimbi [US$289.44 million] of which 57% was Agent product), Guangzhou Wondfo Biotech Co Ltd (1.65 billion Chinese Renmimbi [US$239.97 million] of which 73% was Diagnostic Products), and Maccura Biotechnology Co Ltd (2.66 billion Chinese Renmimbi [US$386.92 million] ).

Sales Analysis. MedicalSystem Biotechnology Co Ltd reported sales of 3.14 billion Chinese Renmimbi (US$455.94 million) for the year ending December of 2018. This represents an increase of 73.7% versus 2017, when the company's sales were 1.81 billion Chinese Renmimbi. Sales at MedicalSystem Biotechnology Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 626%). Sales of Medical Diagnostic Services saw an increase of 89.7% in 2018, from 243.62 million Chinese Renmimbi to 462.25 million Chinese Renmimbi. Not all segments of MedicalSystem Biotechnology Co Ltd experienced an increase in sales in 2018: sales of Others fell 32.4% to 45.40 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
MedicalSystem Biotechnology Co Ltd
  Stock Performance Chart for MedicalSystem Biotechnology Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/17/2019): 14.80
(Figures in Chinese Renmimbi)
1 Week -1.8%   13 Weeks -11.6%  
4 Weeks 0.8%   52 Weeks -39.8%  
 
MedicalSystem Biotechnology Co Ltd Key Data:
  Ticker: 300439 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2018 Sales 3,135,122,920
(Year Ending Jan 2019).
Employees: 2,863
  Currency: Chinese Renmimbi Market Cap: 5,236,821,433
  Fiscal Yr Ends: December Shares Outstanding: 353,839,286
  Share Type: Cls A Ordinary Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.